MedPath

Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Bile Duct Cancer
Pancreatic Cancer
Colorectal Carcinoma
Liver Metastases
Primary Liver Cancer
Gallbladder Cancer
Interventions
Other: Enhanced usual Care
Other: Collaborative Care
Registration Number
NCT01640522
Lead Sponsor
University of Pittsburgh
Brief Summary

The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.

Detailed Description

The study is a collaborative care intervention designed to reduce pain, fatigue, and depressive symptoms and improve overall health related quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
261
Inclusion Criteria
  • biopsy, radiological, and/or biological evidence of hepatobiliary carcinoma
  • age 18 years or older
  • fluency in English. Exclusion criteria included:
Read More
Exclusion Criteria
  • current suicidal or homicidal ideation
  • current psychosis or thought disorder
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Enhanced Usual CareEnhanced usual CareUpon evaluation of symptoms the patient will be referred for further assessment or treatment if indicated
Collaborative Care InterventionCollaborative CareCare coordinator facilitates the assessment and treatment of cancer-related symptoms
Primary Outcome Measures
NameTimeMethod
DepressionChange from baseline at 6 and 12 months

Center for Epidemiological Studies-Depression scale

Secondary Outcome Measures
NameTimeMethod
FatigueChange from baseline at 6 and 12 months

Functional Assessment of Cancer Therapy-Fatigue

Trial Locations

Locations (1)

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath